日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia

Src抑制增强了MCL-1拮抗剂在急性髓系白血病中的活性。

Hu, Xiaoyan; Li, Lin; Nkwocha, Jewel; Kmieciak, Maciej; Shang, Shengzhe; Cowart, L Ashley; Yue, Yang; Horimoto, Katsuhisa; Hawkridge, Adam; Rijal, Arjun; Mauro, Adolfo G; Salloum, Fadi N; Hazlehurst, Lori; Sdrimas, Konstantinos; Moore, Zackary; Zhou, Liang; Ginder, Gordon D; Grant, Steven

Hypochlorous Acid-Gated Hydrolysis of a Phosphinate Ester Dye in Living Cells

次氯酸在活细胞中对膦酸酯染料的水解作用

Fang, Yuan; Zhou, Xinqi; McAfee, Julia L; Faulkner, Benjamin M; Lesiak, Lauren; He, Yuchen; Bro̷ndsted, Frederik; Fan, Hao; Donarski, Eric D; Hu, Xiaoyan; Venton, B Jill; Grant, Steven; Garrett-Bakelman, Francine E; Stains, Cliff I

Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed/refractory multiple myeloma

酸性神经酰胺酶控制蛋白酶体抑制剂耐药性,是治疗复发/难治性多发性骨髓瘤的新型治疗靶点。

Bishop, Ryan T; Li, Tao; Sudalagunta, Praneeth; Nasr, Mostafa; Nyman, Karl J; Alugubelli, Raghunandan R; Meads, Mark; Frieling, Jeremy; Nerlakanti, Niveditha; Tauro, Marilena; Fang, Bin; Grant, Steven; Koomen, John; Silva, Ariosto S; Shain, Kenneth H; Lynch, Conor C

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia

一项随机 II 期研究旨在评估单药纳武利尤单抗在维持急性髓系白血病缓解中的作用。

Pyzer, Athalia R; Dillon, Laura W; Sharon, Elad; Karrison, Theodore G; Zha, Yuanyuan; Fulton, Noreen; Gui, Gege; Andrew, Georgia; Streicher, Howard; Sweet, Kendra; Yaghmour, George; Liu, Jane Jijun; Jonas, Brian A; Schimmer, Aaron D; Grant, Steven; Zeidan, Amer M; Hildebrandt, Gerhard C; Lowrey, Christopher H; Mattison, Ryan J; Palmisiano, Neil; Salhotra, Amandeep; Tzachanis, Dimitrios; Baer, Maria R; Lin, Tara L; Patel, Prapti; Chen, Helen; Stadler, Walter M; Odenike, Olatoyosi; Larson, Richard A; Gajewski, Thomas F; Hourigan, Christopher S; Stock, Wendy; Liu, Hongtao

A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome

MLN4924 和贝利司他治疗复发/难治性急性髓系白血病或骨髓增生异常综合征的 I 期研究

Maher, Keri R; Shafer, Danielle; Schaar, Dale; Bandyopadhyay, Dipankar; Deng, Xiaoyan; Wright, John; Piekarz, Richard; Rudek, Michelle A; Harvey, R Donald; Grant, Steven

Clonal Evolution in 207 Cases of Refractory or Relapsed Acute Myeloid Leukemia

207例难治性或复发性急性髓系白血病的克隆演变

Murray, Graeme F; Bouligny, Ian M; Ho, Thuy; Gor, Juhi; Zacholski, Kyle; Wages, Nolan A; Grant, Steven; Maher, Keri R

Proteasome Inhibition Enhances Lysosome-mediated Targeted Protein Degradation

蛋白酶体抑制增强溶酶体介导的靶向蛋白降解

Elshazly, Ahmed M; Hosseini, Nayyerehalsadat; Shen, Shanwei; Neely, Victoria; Harada, Hisashi; Grant, Steven; Radhakrishnan, Senthil K

Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma

撤稿声明:抑制多种保护性信号通路和Ad.5/3递送可增强mda-7/IL-24疗法治疗恶性胶质瘤

Hamed, Hossein A; Yacoub, Adly; Park, Margaret A; Eulitt, Patrick J; Dash, Rupesh; Sarkar, Devanand; Dmitriev, Igor P; Lesniak, Maciej S; Shah, Khalid; Grant, Steven; Curiel, David T; Fisher, Paul B; Dent, Paul

Accurate detection of acute sleep deprivation using a metabolomic biomarker-A machine learning approach

使用代谢组生物标志物准确检测急性睡眠剥夺——一种机器学习方法

Katherine Jeppe, Suzanne Ftouni, Brunda Nijagal, Leilah K Grant, Steven W Lockley, Shantha M W Rajaratnam, Andrew J K Phillips, Malcolm J McConville, Dedreia Tull, Clare Anderson

Combined MEK1/2 and ATR inhibition promotes myeloma cell death through a STAT3-dependent mechanism in vitro and in vivo

体外和体内实验均表明,MEK1/2 和 ATR 联合抑制可通过 STAT3 依赖性机制促进骨髓瘤细胞死亡。

Li, Lin; Hu, Xiaoyan; Nkwocha, Jewel; Kmieciak, Maciej; Meads, Mark B; Shain, Kenneth H; Alugubelli, Raghunandan R; Silva, Ariosto S; Mann, Hashim; Sudalagunta, Praneeth R; Canevarolo, Rafael R; Zhou, Liang; Grant, Steven